1. HEADLINES
-=6
 Indian Market
Indian equity markets down by 0.05%
Nifty up by down 2.85 pts and settle at
5968.65
Sensex down by 3.04 pts at 19663.55
Bank Nifty up by 84.25 pts at 12802.00
 Global Market
DAILY EQUITY
European markets were up with FTSE
NEWSLETTER up by 7.43 closed at 6106,CAC down by
3.56 closed at 3713 and DAX up by
11TH JANUARY 2013
17.63 closed at 7738.
Dow future was up 31.00 closed at
13356.00
 HEADLINES
• Govt to infuse Rs 12,200cr in PSU
banks; will sell 10% in EIL
• Infosys Q3 net profit seen down 5%
QoQ, USD revenue up 4%
• Tata Steel achieves best ever steel
output in Oct-Dec qtr
• Tata Motors enters Rs 100k-cr club as
shares surge
WWW.EPICRESEARCH.CO 09752199966

2.  MARKET ANALYSIS:
 Key benchmark indices edged lower in choppy trade on political worries after Bahujan Samaj Party
chief Mayawati today, 10 January 2013, sought a rollback of hike in passenger rail fares announced by
the government on Wednesday, 9 January 2013, and after DMK, a key constituent of the Congress led
United Progressive Alliance (UPA) alliance government at the Centre, said that it would take up the
latest railway fare increase issue with Prime Minister Dr. Manmohan Singh. The market breadth was
weak.
 the BSE Sensex was down 14.15 points or 0.07% to 19,652.44
 S&P CNX Nifty was down 9.95 points or 0.17% to 5,961.55.
 Among the 30-share Sensex pack, 23 fell while the rest of them rose.
 Shares of PSU banks were mixed after the Union Cabinet today, 10 January 2013, approved a total
infusion of Rs 12517 crore from Government of India in the form of additional equity capital in public
sector banks during the current financial year. Punjab National Bank and Bank of Baroda rose by
0.01% to 1.48%. Capital goods stocks extended recent losses. ABB, BEML, Bhel, L&T dropped by
0.27% to 2.19%. Pharma stocks declined on profit booking after recent gains. Cipla, Dr Reddy's
Laboratories, Lupin, Ranbaxy Laboratories and Sun Pharmaceutical Industries dropped by 0.06% to
1.2%.
STOCKS TO WATCH
 FII’s and DII’s  INFOSYS
CATEGORY DATE BUY SELL NET  JAI PRAKASH
FII 10-Jan-13 3803.35 3553.85 249.5  TATA MOTORS
 ONGC
DII 10-Jan-13 1340.33 1773.47 -433.14
SCRIPS IN BAN PERIOD
 NIFTY DAILY PIVOTS  SUZLON PUNJLLOYD
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
 KTKBANK IBREALEST
NIFTY 6147 6098 6031 5999 5973 5941 5915 5857 5799
 RENUKA
 IFCI
 IVRCLINFRA
WWW.EPICRESEARCH.CO 09752199966

3. .
 GAINERS AND LOOSERS
EXPERT OPINION
NIFTY
DAILY NIFTY GAINERS
 Nifty looks Consolidate
SCRIPS RATE VOL. PR. NET %
 Strategy: Sell on rise
(000) CLOSE CHAN CHANG
GE E  Support: 5930
ONGC 302.25 9809.96 292.20 10.05 3.44  Resistance: 6020
BANK NIFTY
Tata
333.70 12617.89 327.35 6.35 1.94
Motors  Bank Nifty looks Consolidate
Bank Of
883.65 673.16 870.10 13.55 1.56  Strategy: Sell on rise
Baroda
Axis  Support: 12720
1368.00 1371.87 1349.65 18.35 1.36
Bank
 Resistance: 12870
HDFC
675.80 2282.59 667.50 8.30 1.24  .0
Bank
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
DAILY NIFTY LOOSERS
TATA NOT
SCRIPS RATE VOL. PR. NET % CASH B
MOTORS EXECUTED
(000) CLOSE CHAN CHAN NOT
CASH LT S
GE GE EXECUTED
NOT
Ultratech FUTURE ADANI ENT S
1899.15 683.22 1962.35 -63.20 -3.22 EXECUTED
Cement
Ambuja SUN
191.75 3741.03 197.00 -5.25 -2.66 FUTURE B SL TRIGERRED
Cement PHARMA
BHEL 231.90 4174.88 236.90 -5.00 -2.11
Sesa Goa 193.30 1757.49 196.85 -3.55 -1.80
UPCOMING RESULTS
Hindalco 130.05 10305.04 132.05 -2.00 -1.51 BAJAJ CORP
INFOSYS
CMC
ARTSON ENG
WWW.EPICRESEARCH.CO 09752199966

4. MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS
JAIPRAKASH
SELL 96.00 95.50 94.25 96.50
ASSOCIATE
ONGC BUY 303.00 305.00 308.00 301.00
FUTURE
ST ND
SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS
.
TATA MOTORS BUY 335.80 337.80 340.80 333.80
INFOSYS SELL 2316.00 2300.00 2276.00 2332.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.